We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
KKR Agrees to Buy WebMD Health (WBMD) for $2.8 Billion
Read MoreHide Full Article
Shares of WebMD Health skyrocketed 19.59% in premarket trading on Monday following news that private equity firm KKR & Co. (KKR - Free Report) will buy the online health publisher for $2.8 billion.
KKR will pay $66.50 per share in cash, a 20.5% increase from WebMD’s closing price on Friday.
The deal will bring together WebMD’s websites, such as WebMD.com, Medscape.com, and MedicineNet.com, with those owned by KKR under its Internet Brands unit, including DentalPlans.com and AllAboutCounseling.com.
“We believe that this transaction will provide additional flexibility and resources to deliver increased value to consumers, healthcare professionals, employers, and health plan participants,” said WebMD Chief Executive Steven Zatz.
Founded in 1996, WebMD is best known for its health information services websites, such as WebMD.com, that includes a symptom checklist, pharmacy information, drug information, and more. The company’s sites attracted 179.5 million unique users per month according to WebMD’s fourth quarter 2016 earnings conference call.
In February, WebMD said it would explore strategic alternatives, including possible sale of the company, after advertising paid for by pharmaceutical companies slowed.
The deal is expected to close in the fourth quarter of 2017.
Want to learn more about mergers and acquisitions? Check out our recent podcast on the topic below!
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020. Click here for the 6 trades >>
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.
Image: Bigstock
KKR Agrees to Buy WebMD Health (WBMD) for $2.8 Billion
Shares of WebMD Health skyrocketed 19.59% in premarket trading on Monday following news that private equity firm KKR & Co. (KKR - Free Report) will buy the online health publisher for $2.8 billion.
KKR will pay $66.50 per share in cash, a 20.5% increase from WebMD’s closing price on Friday.
The deal will bring together WebMD’s websites, such as WebMD.com, Medscape.com, and MedicineNet.com, with those owned by KKR under its Internet Brands unit, including DentalPlans.com and AllAboutCounseling.com.
“We believe that this transaction will provide additional flexibility and resources to deliver increased value to consumers, healthcare professionals, employers, and health plan participants,” said WebMD Chief Executive Steven Zatz.
Founded in 1996, WebMD is best known for its health information services websites, such as WebMD.com, that includes a symptom checklist, pharmacy information, drug information, and more. The company’s sites attracted 179.5 million unique users per month according to WebMD’s fourth quarter 2016 earnings conference call.
In February, WebMD said it would explore strategic alternatives, including possible sale of the company, after advertising paid for by pharmaceutical companies slowed.
The deal is expected to close in the fourth quarter of 2017.
Want to learn more about mergers and acquisitions? Check out our recent podcast on the topic below!
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020. Click here for the 6 trades >>